Supporting oncology professionals through education

The content on this site is intended for healthcare professionals only

Videos [1826]

Unmet medical needs and emerging data on EGFR exon 20 insertion mutation NSCLC...

Prof Caicun Zhou - Shanghai Pulmonary Hospital, Shanghai, China

Unmet medical needs and emerging data on EGFR exon 20 insertion mutation NSCLC at ASCO 2021 ( Prof Caicun Zhou - Shanghai Pulmonary Hospital, Shanghai, China )

CodeBreaK 100: Patient-reported outcomes evaluating sotorasib in KRAS p.G12C...

Dr Alex Spira - Virginia Cancer Specialists Research Institute, Fairfax, USA

CodeBreaK 100: Patient-reported outcomes evaluating sotorasib in KRAS p.G12C mNSCLC ( Dr Alex Spira - Virginia Cancer Specialists Research Institute, Fairfax, USA )

Neo-AEGIS: Preliminary results of phase III RCT of CROSS versus perioperative...

Prof John Reynolds - Trinity College Dublin, Dublin, Republic of Ireland

Neo-AEGIS: Preliminary results of phase III RCT of CROSS versus perioperative chemotherapy ( Prof John Reynolds - Trinity College Dublin, Dublin, Republic of Ireland )

Daratumumab, lenalidomide, and dexamethasone versus lenalidomide and...

Prof Thierry Facon - Chu De Lille, Lille, France

Daratumumab, lenalidomide, and dexamethasone versus lenalidomide and dexamethasone in transplant-ineligible newly diagnosed MM ( Prof Thierry Facon - Chu De Lille, Lille, France )

Latest updates in exon 20 insertions focusing on targeted therapies, novel...

Dr Mathew Krebs, Dr Santiago Viteri, Dr Shirish Gadgeel and Prof Byoung Chul Cho

Latest updates in exon 20 insertions focusing on targeted therapies, novel approaches, and implications for patients ( Dr Mathew Krebs, Dr Santiago Viteri, Dr Shirish Gadgeel and Prof Byoung Chul Cho )

Breast cancer roundup from ASCO 2021

Dr Matteo Lambertini - San Martino Hospital, Genoa, Italy

Breast cancer roundup from ASCO 2021 ( Dr Matteo Lambertini - San Martino Hospital, Genoa, Italy )

OncoAlert and ecancer ASCO roundup - Day 4 and 5

Dr Gil Morgan - Skåne University Hospital in Lund, Sweden

OncoAlert and ecancer ASCO roundup - Day 4 and 5 ( Dr Gil Morgan - Skåne University Hospital in Lund, Sweden )

ADT plus TAK-700 with ADT plus bicalutamide in patients with newly diagnosed...

Prof Neeraj Agarwal - Huntsman Cancer Institute, University of Utah, Salt Lake...

ADT plus TAK-700 with ADT plus bicalutamide in patients with newly diagnosed mHSPC ( Prof Neeraj Agarwal - Huntsman Cancer Institute, University of Utah, Salt Lake City, USA )

GLOW: Fixed-duration ibrutinib and venetoclax for first-line CLL

Prof Arnon Kater - Amsterdam University Medical Centre, Amsterdam, The...

GLOW: Fixed-duration ibrutinib and venetoclax for first-line CLL ( Prof Arnon Kater - Amsterdam University Medical Centre, Amsterdam, The Netherlands )

Brentuximab vedotin with chemotherapy for advanced classical Hodgkin lymphoma

Dr Martin Hutchings - Copenhagen University Hospital, Copenhagen, Denmark

Brentuximab vedotin with chemotherapy for advanced classical Hodgkin lymphoma ( Dr Martin Hutchings - Copenhagen University Hospital, Copenhagen, Denmark )

Developments in metastatic hormone-sensitive prostate cancer

Prof Karim Fizazi, Prof Alicia Morgans, Prof Neeraj Agarwal and Prof Laura...

Developments in metastatic hormone-sensitive prostate cancer ( Prof Karim Fizazi, Prof Alicia Morgans, Prof Neeraj Agarwal and Prof Laura-Maria Krabbe )

Marizomib in combination with temozolomide-based radiochemotherapy for newly...

Dr Patrick Roth - University Hospital Zurich, Zurich, Switzerland

Marizomib in combination with temozolomide-based radiochemotherapy for newly diagnosed glioblastoma ( Dr Patrick Roth - University Hospital Zurich, Zurich, Switzerland )

More from ecancer